Washington Drug Letter
Oct. 8, 2012
| Vol.
44 No.
40
FDA Sets Dec. 3 as GDUFA Self-Identification Deadline
Generic-drug makers must submit self-identification information to the FDA by Dec. 3 to comply with the recently passed Generic Drug User Fee Amendments of 2012.
This article is viewable by subscribers only. To view this article, please select an option below.
|